---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-007228"
form_type: "8-K"
ticker: "DMRA"
cik: "0001800315"
company_name: "Damora Therapeutics, Inc."
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T05:42:51.490637+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Galecto discloses SVB exposure under $1.5M; no material impact expected

## Summary
- FDIC took control of Silicon Valley Bank on March 10, 2023 due to liquidity concerns.
- Galecto's cash deposits at SVB total less than $1.5 million, excluding FDIC-insured amounts.
- Company does not anticipate any material effect on its operating plan or cash runway.

## SEC filing metadata
- accession: 0000950170-23-007228
- form_type: 8-K
- ticker: DMRA
- cik: 0001800315
- company_name: Damora Therapeutics, Inc.
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800315/000095017023007228/0000950170-23-007228-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800315/000095017023007228/glto-20230310.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-007228
- JSON: https://secwatch.observer/filing/0000950170-23-007228.json
- Plain text: https://secwatch.observer/filing/0000950170-23-007228.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.